Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Veritas To Market Epistem’s Services in Japan | Contract Pharma

What are you searching for?

Sign in
Breaking News

Veritas To Market Epistem’s Services in Japan

Veritas Corp. has entered into an agreement with to market and distribute Epistem’s scientific research services in Japan.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Veritas Corp. has entered into an agreement with to market and distribute Epistem’s scientific research services in Japan. Epistem’s contract research division, located in Manchester England, provides specialized preclinical and scientific research services to drug development and personal care companies in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Epistem has a customer base in western Europe and the U.S and the Veritas agreement will provide a sales and marketing presence in Japan.

Epistem’s chief executive officer, Matthew Walls, said, “We are delighted to be working with Veritas. They have a strong scientific sales team and established distribution network. The Japanese drug development market provides us with an important opportunity for growth and the agreement with Veritas will allow us to develop closer links with existing Japanese customers.”

Sinsaku Iida, Veritas’ chief executive officer, said, ”It is our great pleasure to work with Epistem. Epistem’s Contract Research Division has a strong preclinical and scientific research service capability, which will benefit Japanese pharmaceutical and personal care companies. Veritas’ sales network has the scientific experience necessary to introduce Epistem’s high quality services to potential Japanese customers and will make for more efficient marketing and easier access for Japanese customers to Epistem.“

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics